{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:07:36Z","timestamp":1790446056613,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Kazakhstan has a high burden of multidrug-resistant tuberculosis (TB). The patient-centered National Program for the treatment and prevention of TB has been implemented in Kazakhstan. The program is aimed at meeting the needs of patients and expansion of the outpatient treatment of TB in the country.<\/jats:p>\n            <jats:p>The aim of the study was to compare the efficacy of the outpatient and inpatient treatment of drug-susceptible TB.<\/jats:p>\n            <jats:p>This study was a retrospective cohort study.<\/jats:p>\n            <jats:p>A total of 36.926 TB cases were included. The majority of patients were treated as inpatients. The socioeconomic factors, sex, age, HIV status, and other diagnostic factors (e.g., sputum smear results, extrapulmonary disease) may serve as risk factors to estimate the likely TB treatment outcome. The outpatient treatment of drug-susceptible TB seems to be a comparable option to the inpatient treatment in terms of efficacy.<\/jats:p>\n            <jats:p>The socioeconomic factors are the main modifiable risk factors for treatment failure. The outpatient treatment of drug-susceptible TB is safe and effective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016071","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:22:52Z","timestamp":1561728172000},"page":"e16071","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective analysis of treatment outcomes of drug-susceptible TB in Kazakhstan, 2013\u20132016"],"prefix":"10.1097","volume":"98","author":[{"given":"Laura","family":"Sadykova","sequence":"first","affiliation":[{"name":"Asfendiyarov Kazakh National Medical University, Department of Public Heath, Almaty, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvijus","family":"Abramavi\u010dius","sequence":"additional","affiliation":[{"name":"Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences, Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talgat","family":"Maimakov","sequence":"additional","affiliation":[{"name":"South Kazakhstan Medical Academy, Department of \u201cPediatrics and Children's Surgery,\u201d Shymkent, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Berikova","sequence":"additional","affiliation":[{"name":"National Scientific Center of Phthisiopulmonology, Almaty, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kural","family":"Kurakbayev","sequence":"additional","affiliation":[{"name":"Department of \u201cPublic Health Economics,\u201d Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan T.","family":"Carr","sequence":"additional","affiliation":[{"name":"California State University, Fullerton, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017dilvinas","family":"Padaiga","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albinas","family":"Naud\u017ei\u016bnas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgaras","family":"Stankevi\u010dius","sequence":"additional","affiliation":[{"name":"Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences, Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.13-0004","article-title":"A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis","volume":"89","author":"Bassili","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11595340-000000000-00000","article-title":"A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis","volume":"30","author":"Fitzpatrick","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12879-018-3636-1","article-title":"Cost of three models of care for drug-resistant tuberculosis patients in Nigeria","volume":"19","author":"Bada","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijid.2017.09.029","article-title":"Video Directly Observed Therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study","volume":"65","author":"Nguyen","year":"2017","journal-title":"Int J Infect Dis"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"e1000427","DOI":"10.1371\/journal.pmed.1000427","article-title":"Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study","volume":"8","author":"Jones-L\u00f3pez","year":"2011","journal-title":"PLoS Med"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JCM.00718-11","article-title":"Cepheid GeneXpert MTB\/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results","volume":"49","author":"Ioannidis","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/JCM.39.12.4440-4444.2001","article-title":"Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis","volume":"39","author":"Ardito","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.05.00111304","article-title":"Drug-susceptibility testing in tuberculosis: methods and reliability of results","volume":"25","author":"Kim","year":"2005","journal-title":"Eur Respir J"},{"key":"R15-20230914","first-page":"20455","article-title":"WHO revised definitions and reporting framework for tuberculosis","volume":"18","year":"2013","journal-title":"Euro Surveill"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13561-016-0100-z","article-title":"Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan","volume":"6","author":"Kohler","year":"2016","journal-title":"Health Econ Rev"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3889\/oamjms.2015.050","article-title":"Comparison of results from inpatient and outpatient treatment of tuberculosis in Republic of Macedonia","volume":"3","author":"Simonovska","year":"2015","journal-title":"Open access Maced J Med Sci"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1590\/S1806-37132011000600012","article-title":"Outcomes of tuberculosis treatment among inpatients and outpatients in the city of S\u00e3o Paulo, Brazil","volume":"37","author":"Perrechi","year":"2011","journal-title":"J Bras Pneumol"},{"key":"R19-20230914","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0028-2016","article-title":"Tuberculosis associated with HIV infection","volume":"5","author":"Tornheim","year":"2017","journal-title":"Microbiol Spectr"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40545-017-0124-8","article-title":"Evaluating treatment outcomes and durations among cases of smear-positive pulmonary tuberculosis in Yemen: a prospective follow-up study","volume":"10","author":"Jaber","year":"2017","journal-title":"J Pharm Policy Pract"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/ijmy.ijmy_69_17","article-title":"Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: a retrospective study","volume":"6","author":"Ahmad","year":"2017","journal-title":"Int J Mycobacteriol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/eurpub\/ckx136","article-title":"Unsuccessful treatment in pulmonary tuberculosis: factors and a consequent predictive model","volume":"28","author":"Costa-Veiga","year":"2017","journal-title":"Eur J Public Health"},{"key":"R23-20230914","first-page":"612","article-title":"Risk of treatment failure in patients with drug-susceptible pulmonary tuberculosis in China","volume":"29","author":"Wang","year":"2016","journal-title":"Biomed Environ Sci"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5588\/pha.14.0040","article-title":"Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006-2010","volume":"4","author":"Lucenko","year":"2014","journal-title":"Public Heal Action"},{"key":"R25-20230914","first-page":"671","article-title":"Role of diabetes mellitus on treatment effects in drug-susceptible initial pulmonary tuberculosis patients in China","volume":"30","author":"Ma","year":"2017","journal-title":"Biomed Environ Sci"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"e4540","DOI":"10.1097\/MD.0000000000004540","article-title":"Clinical significance of smear positivity for acid-fast bacilli after \u22655 months of treatment in patients with drug-susceptible pulmonary tuberculosis","volume":"95","author":"Kang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"e0142384","DOI":"10.1371\/journal.pone.0142384","article-title":"Determinants of default from tuberculosis treatment among patients with drug-susceptible tuberculosis in Karachi, Pakistan: a mixed methods study","volume":"10","author":"Chida","year":"2015","journal-title":"PLoS One"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12879-017-2810-1","article-title":"Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis","volume":"17","author":"Bastos","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/trstmh\/trx074","article-title":"High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study","volume":"111","author":"Thu","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/IDR.S153499","article-title":"Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis","volume":"11","author":"Lv","year":"2018","journal-title":"Infect Drug Resist"},{"key":"R31-20230914","article-title":"OUP accepted manuscript","author":"Yu","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"(Suppl. 3)","key":"R32-20230914","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.5588\/pha.14.0058","article-title":"Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa, Ethiopia","volume":"4","author":"Fiseha","year":"2014","journal-title":"Public Heal action"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201906280-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T22:11:08Z","timestamp":1694729468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201906280-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":27,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016071","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}